Fremont, California, April 26, 2026, 09:01 (PDT)
- AXT’s underwriters picked up an additional 1.28 million shares, tacking on roughly $82.5 million to the company’s already sizable equity offering.
- The company is set to boost indium phosphide output at its Beijing Tongmei wafer unit in China, allocating more funding to expand capacity.
- There’s a simpler growth narrative for investors now, though they’re also staring down increased share supply and the lingering issue of China’s export permits.
AXT, Inc. reported that underwriters picked up their option for another 1,284,046 shares at $64.25 apiece, tacking on roughly $82.5 million in gross proceeds to a public offering that had previously brought in about $550 million. With this latest purchase, the Fremont, California-based semiconductor materials maker’s gross tally comes to around $632.5 million, before subtracting underwriting discounts, commissions, and related expenses.
AXT is tapping the market for fresh capital just as investors have piled into companies linked to AI data-center infrastructure. The focus here: indium phosphide, or InP—AXT’s main play in this space. It’s a compound semiconductor crucial for the laser-based data links that shuttle vast data loads through data centers and telecom networks.
AXT plans to direct most of the proceeds to its subsidiary, Beijing Tongmei Xtal Technology Co., Ltd., which is scaling up InP substrate production for export markets. The remainder will go toward R&D, working capital, and other general needs.
AXT wrapped up its base offering on April 22, moving 8,560,311 shares at $64.25 apiece. Northland Capital Markets took the sole bookrunner role. Needham & Company, B. Riley Securities, Craig-Hallum, and Wedbush Securities were tapped as co-managers.
That’s a hefty raise for a company that pulled in $88.3 million in revenue for 2025. In its filing, AXT breaks out $58.9 million from substrates and $29.4 million from raw materials and other segments last year. These numbers highlight the amount of new capacity investors are being asked to value before those sales show up.
AXT hasn’t released its first-quarter numbers yet. According to the prospectus supplement, management projected revenue for the March quarter would fall between $26 million and $28 million. Net loss? Somewhere in the range of $1.6 million to $2.6 million, or a per-share loss of 3 to 5 cents. The company flagged the figures as preliminary—final results may shift once closing work wraps up.
The clock’s ticking for AXT’s next update: first-quarter results drop after the bell on April 30, with the earnings call lined up for 1:30 p.m. Pacific that same day.
AXT closed at $76.16 on April 24, gaining 1.18%, latest market figures show. Shares swung between a top above $81 and a dip near $69 during a choppy session. Those swings have pushed the once-small materials supplier into the spotlight for traders focused on optical-connectivity.
Chips aren’t its game. Instead, the company produces wafers—the foundational material others use to assemble devices—out of InP, gallium arsenide and germanium, especially when regular silicon falls short on speed, thermal tolerance or optical needs. According to AXT, every substrate and raw-material product comes out of China, made by its PRC subsidiaries and joint ventures.
AXT faces no shortage of competition. Its latest annual filing lists Sumitomo Electric Industries, JX, and Freiberger Compound Materials as key players in the compound and single-element semiconductor substrate space. Customers tend to line up at least two qualified substrate suppliers, the company notes. Here, share can move fast—delivery times and reliability matter.
The risk factor is hard to ignore. AXT disclosed that China’s export rules mandate permits for every Tongmei wafer-substrate product line. Permits are in place for InP exports headed to Europe, Japan, the UK, and Canada. For U.S. buyers, though, permits remained under final review—none had been granted when the prospectus was filed.
So, the latest funding leaves the core policy risk unresolved. AXT warned that if export permits are delayed, the gap between purchase orders and revenue recognition under U.S. accounting rules could widen—potentially hitting its business, financial condition, and operating results in a material way.
